We Can Help
If you have questions about eligibility, please contact us at 719.633.3400.
Guidelines Introduction
Patients who meet the Centers for Medicare and Medicaid Services hospice eligibility guidelines provided here are expected to have a life expectancy of six months or less if the terminal illness runs its normal course. Some patients may not meet these guidelines, yet may still be eligible for hospice care if there are other general indicators of decline such as weight loss, increased sleepiness, history of falls or hospitalizations and more. A physician reviews each patient’s history and current condition to determine hospice eligibility. If a patient improves while in hospice such that he/she no longer has a prognosis of six months or less, that patient will be considered for discharge from hospice care. Such patients can be re-enrolled in the future if they experience a decline in their clinical status and their prognosis again is 6 months or less.
A patient will be considered to have a life expectancy of six months or less if he/she meets the non-disease specific decline in clinical status guidelines described in Part I. Alternatively, the baseline non-disease specific guidelines described in Part II plus the applicable disease specific guidelines listed in the appendix will establish the necessary expectancy.
These changes in clinical variables apply to patients whose decline is not considered to be reversible. They are listed in order of their likelihood to predict poor survival, the most predictive first and the least predictive last. No specific number of variables must be met, but fewer of those listed first (more predictive) and more of those listed last (least predictive) would be expected to predict longevity of six months or less.
Part I. Decline in clinical status guidelines
Patients will be considered to have a life expectancy of six months or less if there is documented evidence of decline in clinical status based on the guidelines below.
-
- Progression of disease as documented by worsening clinical status, symptoms, signs and laboratory results:
- Clinical Status
- Recurrent or intractable infections such as pneumonia, sepsis or upper urinary tract.
- Progressive inanition as documented by:
- Weight loss not due to reversible causes i.e. depression/diuretic use
- Decreasing anthropomorphic measurements (mid-arm circumference, abdominal girth)
- Decreasing serum albumin/cholesterol
- Dysphagia leading to recurrent aspiration and/or inadequate oral intake documented by decreasing food portion consumption
- Symptoms
- Dyspnea with increasing respiratory rate
- Cough, intractable
- Nausea/vomiting poorly responsive to treatment
- Diarrhea, intractable
- Pain requiring increasing doses of major analgesics more than briefly
- Signs
- Decline in systolic blood pressure to below 90 or progressive postural hypotension
- Ascites
- Venous, arterial or lymphatic obstruction due to local progression or metastatic disease
- Edema
- Pleural/pericardial effusion
- Weakness
- Change in level of consciousness
- Laboratory (when available)
- Increasing pCO2 or decreasing pO2 or decreasing SaO2
- Increasing calcium, creatinine or liver function studies
- Increasing tumor markers (e.g. CEA, PSA)
- Progressively decreasing or increasing serum sodium or increasing serum potassium
- Clinical Status
- Decline in Karnofsky or Palliative Performance Score (PPS) from <70% due to progression of disease.
- Increasing ER visits, hospitalizations, or physician’s visits related to hospice primary diagnosis.
- Progressive decline in Functional Assessment Staging (FAST) for dementia (from 7A on the FAST).
- Progression to dependence w/additional ADLs (See Part II, Section 2).
- Progressive stage 3-4 pressure ulcers in spite of optimal care.
- Progression of disease as documented by worsening clinical status, symptoms, signs and laboratory results:
Part II. Non-disease specific baseline guidelines (both should be met)
- Physiologic impairment of functional status as demonstrated by: Karnofsky or Palliative Performance Score (PPS) <70%. Note that HIV & Stroke and Coma establish a lower qualifying KPS or PPS.
- Dependence on assistance for 2 or more activities of daily living (ADLs):
- Feeding
- Ambulation
- Continence
- Transfer
- Bathing
- Dressing
Part III. Co-morbidities
Although not the primary hospice diagnosis, the presence of disease such as the following, the severity of which is likely to contribute to a life expectancy of six months or less, should be considered in determining hospice eligibility.
- COPD
- CHF
- Ischemic heart disease
- Diabetes mellitus
- Neurologic disease (CVA, ALS, MS, Parkinson’s)
- Renal failure
- Liver Disease
- Neoplasia
- Acquired immune deficiency syndrome
- Dementia
Disease-Specific Guidelines for Hospice Eligibility
General Considerations:
- ALS tends to progress in a linear fashion over time. Thus the overall rate of decline in each patient is fairly constant and predictable.
- However, no single variable deteriorates at a uniform rate in all patients. Therefore, multiple clinical parameters are required to judge the progression of ALS.
- Although ALS usually presents in a localized anatomical area, the location of initial presentation does not correlate with survival time. By the time patients become end-stage, muscle denervation has become widespread, affecting all areas of the body, and initial predominance patterns do not persist.
- Progression of disease differs markedly from patient to patient. Some patients decline rapidly and die quickly; others progress more slowly. For this reason, the history of the rate of progression in individual patients is important to obtain to predict prognosis.
- In end-state ALS, two factors are critical in determining prognosis: ability to breathe, and to a lesser extent, ability to swallow. The former can be managed by artificial ventilation, and the latter by gastrostomy or other artificial feeding, unless the patient has recurrent aspiration pneumonia. While not necessarily a contraindication to hospice care, the decision to institute either artificial ventilation or artificial feeding will significantly alter six-month prognosis.
- Examination by a neurologist within three months of assessment for hospice is advised, both to confirm the diagnosis and to assist with prognosis.
Criteria:
Patients will be considered to be in the terminal stage of ALS if: (Should fulfill 1, 2, or 3).
- Patient should demonstrate critically impaired breathing capacity.
- Critically impaired breathing capacity as demonstrated by all the following characteristics occurring within the 12 months preceding initial hospice certification:
- Vital capacity (VC) less than 30% of normal (if available)
- Dyspnea at rest
- Patient declines mechanical ventilation; external ventilation used for comfort measures only
- Critically impaired breathing capacity as demonstrated by all the following characteristics occurring within the 12 months preceding initial hospice certification:
- Patient should demonstrate both rapid progression of ALS and critical nutritional impairment.
- Rapid progression of ALS as demonstrated by all the following characteristics occurring within the 12 months preceding initial hospice certification:
- Progression from independent ambulation to wheelchair to bed bound status
- Progression from normal to barely intelligible or unintelligible speech
- Progression from normal to pureed diet
- Progression from independence in most or all activities of daily living (ADLs) to needing major assistance by caretaker in all ADLs
- Critical nutritional impairment as demonstrated by all the following characteristics occurring within the 12 months preceding initial hospice certification:
- Oral intake of nutrients and fluids insufficient to sustain life
- Continuing weight loss
- Dehydration or hypovolemia
- Absence of artificial feeding methods, sufficient to sustain life, but not for relieving hunger
- Rapid progression of ALS as demonstrated by all the following characteristics occurring within the 12 months preceding initial hospice certification:
- Patient should demonstrate both rapid progression of ALS and life-threatening complications.
- Rapid progression of ALS, see 2.a above.
- Life-threatening complications as demonstrated by one of the following characteristics occurring within the 12 months preceding initial hospice certification:
- Recurrent aspiration pneumonia (with or without tube feedings)
- Upper urinary tract infection, e.g., pyelonephritis
- Sepsis
- Recurrent fever after antibiotic therapy
- Stage 3 or 4 decubitus ulcer(s)
- Disease with distant metastases at presentation OR
- Progression from an earlier stage of disease to metastatic disease with either:
- Continued decline in spite of therapy
- Patient declines further disease directed therapy
Note: Certain cancers w/poor prognoses (e.g. small cell lung, brain, and pancreatic cancer) may be hospice eligible without fulfilling the other criteria in this section.
Due to Alzheimer’s Disease and Related Disorders
Patients with dementia should show all the following:
- Stage 7 or beyond according to the Functional Assessment Staging Scale
- Unable to ambulate without assistance
- Unable to dress without assistance
- Unable to bathe without assistance
- Urinary and fecal incontinence, intermittent or constant
- No consistently meaningful verbal communication: stereotypical phrases only or the ability to speak is limited to six or fewer intelligible words
Patients should have had one of the following within the past 12 months:
- Aspiration pneumonia
- Pyelonephritis or other upper urinary tract infection
- Septicemia
- Decubitus ulcers, multiple, stage 3-4
- Fever, recurrent after antibiotics
- Inability to maintain sufficient fluid and calorie intake with 10% weight loss during the previous six months or serum albumin <2.5 gm/dl
Note: This section is specific for Alzheimer’s Disease and related disorders, and is not appropriate for other types of dementia, such as multi-infarct dementia.
- At the time of initial certification or recertification for hospice, the patient is or has been already optimally treated for heart disease or is not a candidate for a surgical procedure or has declined a procedure. (Optimally treated means that patients who are not on vasodilators have a medical reason for refusing these drugs, e.g., hypotension or renal disease.)
- The patient is classified as New York Heart Association (NYHA) Class IV and may have significant symptoms of heart failure or angina at rest. (Class IV patients with heart disease have an inability to carry on any physical activity without discomfort. Symptoms of heart failure or of the anginal syndrome may be present even at rest. If any physical activity is undertaken, discomfort is increased.) Significant congestive heart failure may be documented by an ejection fraction of ≤ 20%, but is not required if not already available.
- Documentation of the following factors will support but is not required to establish eligibility for hospice care:
- Treatment resistant symptomatic supraventricular or ventricular arrhythmias
- History of cardiac arrest or resuscitation
- History of unexplained syncope
- Brain embolism of cardiac origin
- Concomitant HIV disease
- CD4+ Count <25 cells/mcl or persistent (2 or more assays at least one month apart) viral load >100,000 copies/ml, plus one of the following:
- CNS lymphoma
- Untreated, or persistent despite treatment, wasting (loss of at least 10% lean body mass)
- Mycobacterium avium complex (MAC) bacteremia, untreated, unresponsive to treatment, or treatment refused
- Progressive multifocal leukoencephalopathy
- Systemic lymphoma, with advanced HIV disease and partial response to chemotherapy
- Visceral Kaposi’s sarcoma unresponsive to therapy
- Renal failure in the absence of dialysis
- Cryptosporidium infection
- Toxoplasmosis, unresponsive to therapy
- Decreased performance status, as measured by the Karnofsky Performance Status (KPS) scale or Palliative Performance (PPS) scale, of ≤ 50%.
- Documentation of the following factors will support eligibility for hospice care:
- Chronic persistent diarrhea for one year
- Persistent serum albumin <2.5
- Concomitant, active substance abuse
- Age >50 years
- Absence of, or resistance to effective antiretroviral, chemotherapeutic and prophylactic drug therapy related specifically to HIV disease
- Advanced AIDS dementia complex
- Toxoplasmosis
- Congestive heart failure, symptomatic at rest
- Advanced liver disease
- The patient should show both a and b:
- Prothrombin time prolonged more than 5 seconds over control, or International Normalized Ratio (INR) >1.5
- Serum albumin <2.5 gm/dl
- End stage liver disease is present and the patient shows at least one of the following:
- Ascites, refractory to treatment or patient non-compliant
- Spontaneous bacterial peritonitis
- Hepatorenal syndrome (elevated creatinine and BUN with oliguria (<400 ml/day) and urine sodium concentration <10 mEq/l
- Hepatic encephalopathy, refractory to treatment, or patient non-compliant
- Recurrent variceal bleeding, despite intensive therapy
- Documentation of the following factors will support eligibility for hospice care:
- Progressive malnutrition
- Muscle wasting with reduced strength and endurance
- Continued active alcoholism (>80 gm ethanol/day
- Hepatocellular carcinoma
- HBsAg (Hepatitis B) positivity
- Hepatitis C refractory to interferon treatment
Patients awaiting liver transplant who otherwise fit the above criteria may be certified for the Medicare hospice benefit, but if a donor organ is procured, the patient should be discharged from hospice.
- Severe chronic lung disease as documented by both a and b:
- Disabling dyspnea at rest, poorly or unresponsive to bronchodilators, resulting in decreased functional capacity, e.g., bed to chair existence, fatigue, and cough: (Documentation of Forced Expiratory Volume in One Second (FEV1), after bronchodilator, less than 30% of predicted is objective evidence for disabling dyspnea, but is not necessary to obtain)
- Progression of end stage pulmonary disease, as evidenced by increasing visits to the emergency department or hospitalizations for pulmonary infections and/or respiratory failure or increasing physician home visits prior to initial certification. (Documentation of serial decrease of FEV1>40 ml/year is objective evidence for disease progression, but is not necessary to obtain)
- Hypoxemia at rest on room air, as evidenced by pO2 ≤ 55 mmHg; or oxygen saturation ≤ 88% on supplemental oxygen determined either by arterial blood gases or oxygen saturation monitors; (these values may be obtained from recent hospital records). OR Hypercapnia, as evidenced by pCO2 ≥ 50 mmHg. (This value may be obtained from recent [within 3 months] hospital records)
- Right heart failure (RHF) secondary to pulmonary disease (Cor pulmonale) (e.g., not secondary to left heart disease or valvulopathy)
- Unintentional progressive weight loss of greater than 10% of body weight over the preceding six months
- Resting tachycardia >100/minute
Acute renal failure:
(1 and either 2 or 3 should be present. Factors from 4 will lend supporting documentation.)
- The patient is not seeking dialysis or renal transplant or is discontinuing dialysis
- Creatinine clearance <10 cc/min (<15 cc/min. for diabetics) based on measurement or calculation; or <15cc/min (<20cc/min for diabetics) with comorbidity of congestive heart failure
- Serum creatinine >8.0 mg/dl (>6.0 mg/dl for diabetics)
- Comorbid conditions:
- Mechanical ventilation
- Malignancy (other organ system)
- Chronic lung disease
- Advanced cardiac disease
- Advanced liver disease
- Sepsis
- Immunosuppression/AIDS
- Albumin <3.5 gm/dl
- Cachexia
- Platelet count <25,000
- Disseminated intravascular coagulation
- Gastrointestinal bleeding
Chronic renal failure:
(1 and either 2 or 3 should be present. Factors from 4 will lend supporting documentation.)
- The patient is not seeking dialysis or renal transplant or is discontinuing dialysis
- Creatinine clearance <10 cc/min (<15 cc/min for diabetics) based on measurement or calculation; or <15cc/min (<20cc/min for diabetics) with comorbidity of congestive heart failure
- Serum creatinine >8.0 mg/dl (>6.0 mg/dl for diabetics)
- Signs and symptoms of renal failure:
- Uremia
- Oliguria (<400 cc/24 hours)
- Intractable hyperkalemia (>7.0) not responsive to treatment
- Uremic pericarditis
- Hepatorenal syndrome
- Intractable fluid overload, not responsive to treatment
Stroke:
- Karnofsky (KPS) or Palliative Performance Scale (PPS) of 40% or less
- Inability to maintain hydration and caloric intake with one of the following:
- Weight loss >10% in the last 6 months or >7.5% in the last 3 months
- Serum albumin <2.5 gm/dl
- Current history of pulmonary aspiration not responsive to speech language pathology intervention
- Sequential calorie counts documenting inadequate caloric/fluid intake
- Dysphagia severe enough to prevent the patient from receiving food and fluids necessary to sustain life, in a patient who declines or does not receive artificial nutrition and hydration
Coma (any etiology):
Comatose patients with any 3 of the following on day three of coma:
- Abnormal brain stem response
- Absent verbal response
- Absent withdrawal response to pain
- Serum creatinine >1.5 mg/dl
Documentation of the following factors will support eligibility for hospice care:
Documentation of medical complications, in the context of progressive clinical decline, within the previous 12 months, which support a terminal prognosis:
- Aspiration pneumonia
- Upper urinary tract infection (pyelonephritis)
- Sepsis
- Refractory stage 3-4 decubitus ulcers
- Fever recurrent after antibiotics
Documentation of diagnostic imaging factors which support poor prognosis after stroke include:
- For non-traumatic hemorrhagic stroke:
- Large-volume hemorrhage on CT:
- Infratentorial: ≥20 ml.
- Supratentorial: ≥50 ml.
- Ventricular extension of hemorrhage
- Surface area of involvement of hemorrhage ≥30% of cerebrum
- Midline shift ≥1.5 cm.
- Obstructive hydrocephalus in patient who declines, or is not a candidate for, ventriculoperitoneal shunt
- Large-volume hemorrhage on CT:
- For thrombotic/embolic stroke:
- Large anterior infarcts with both cortical and subcortical involvement
- Large bihemispheric infarcts
- Basilar artery occlusion
- Bilateral vertebral artery occlusion
Supportive Documentation for GIP
Upon transfer to GIP level of care, documentation should include both:
- A precipitating event (onset of uncontrolled symptoms or pain)
- The interventions tried that were unsuccessful at controlling the symptoms
Pain Control:
- Frequent evaluation by a doctor or nurse Frequent medication adjustment
- IVs that cannot be administered at home Aggressive pain management
- Complicated technical delivery of medication
Symptom Control:
- Sudden deterioration requiring intensive nursing intervention Uncontrolled nausea or vomiting
- Pathological fractures
- Open wounds requiring frequent skilled care Unmanageable respiratory distress
- New or worsening delirium
The POC should reflect the change in the level of care, the beneficiary’s response, and collaboration with facility staff.
Tools for Determining Eligibility
Functional Assessment Staging (FAST)
- Improperly putting on clothing without assistance or cueing (e.g., may put street clothes on over night clothes, or put shoes on wrong feet, or have difficulty buttoning clothing) occasionally or more frequently over the past weeks
- Unable to bathe properly (e.g., difficulty adjusting bath-water temperature) occasionally or more frequently over the past weeks
- Inability to handle mechanics of toileting (e.g., forgets to flush the toilet, does not wipe properly or properly dispose of toilet tissue) occasionally or more frequently over the past weeks
- Urinary incontinence (occasionally or more frequently over the past weeks)*
- Fecal incontinence (occasionally or more frequently over the past weeks)*
- Ability to speak limited to approximately six intelligible different words or fewer in the course of an average day or in the course of an intensive interview
- Speech ability is limited to the use of a single intelligible word in an average day or in the course of an intense interview. (The person may repeat the word over and over)
- Ambulatory ability is lost (cannot walk without personal assistance)
- Cannot sit up without assistance (e.g., the individual will fall over if there are not lateral rests [arms] on the chair)
- Loss of ability to smile
- Loss of ability to hold head up independently
*Scored primarily on the basis of information obtained from knowledgeable informant and/or category. Reisburg, B. Functional assessment staging (FAST). Psychopharmacology Bulletin. 1988; 24:653-659.
New York Heart Association Class Scale Functional Capacity
- Class I. Patients with cardiac disease but without resulting limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea or anginal pain
- Class II. Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea or anginal pain
- Class III. Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea or anginal pain
- Class IV. Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest
Palliative Performance Scale (PPS)
Pain Scale
0 – 10 Numeric Pain Intensity Scale
FLACC Scale
Scoring
Note: Each of the five categories Face (F), Legs (L), Activity (A), Cry (C), and Consolability (c) is scored from 0-2, which results in a total score of 0-10.
From Merkel, Voepel-Lewis, Shayevitz, & Malviya (1997). The FLACC: A behavioral scale for scoring postoperative pain in young children. Pediatric Nursing, 23(3) 293-297.
Source: Pediatric Nursing ©2003 Jannetti Publications, Inc.